Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus.
about
Serum adenosine deaminase and cytidine deaminase activities in patients with systemic lupus erythematosusIL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adultsMonocyte activation in patients with Wegener's granulomatosis.Tumour necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6) and their soluble receptors (sTNF-alpha-Rp55 and slL-6R) serum levels in systemic lupus erythematodes.Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity.Pharmacokinetic and pharmacodynamic relationship of AMG 811, an anti-IFN-γ IgG1 monoclonal antibody, in patients with systemic lupus erythematosus.An immunosuppressive subtype of neutrophils identified in patients with hepatocellular carcinoma.Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritisSoluble Receptors for Tumor Necrosis Factor and Neopterin as Parameters of Cell-Mediated Immune Activation.Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease?In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors.A multicenter photoprovocation study to identify potential biomarkers by global peptide profiling in cutaneous lupus erythematosus.
P2860
Q28214358-8DDAD2C5-3C07-44E1-8FE9-002B45B2F107Q35044152-F5B50484-3AFD-4ADC-818E-AB20BB47FE62Q35548500-14CA7946-299C-49EB-8581-C0E282FA464FQ36628172-5D35A684-1F14-4B0A-A000-E15171766A29Q36990282-85E72875-131C-4CE0-807C-6713EE2BFB6FQ39130536-68F6B2FE-34D5-4B5E-AD84-5CBC2075BA1FQ41435464-A6B62776-3148-4A1E-8829-58945466AF48Q42360801-B451B1FA-1FCB-498A-9E29-C53BEABB2B0EQ42599546-422072E8-5C0E-4B40-A38D-2E6AD3D30498Q45971256-33109525-228D-40D3-AA32-E1035B8A021FQ53304078-9CCB901D-40B8-4A3B-A86D-33A916EC0419Q53410409-6FD86F82-8A06-4C66-9793-C6DC27F1A25C
P2860
Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Serum soluble markers of immun ...... systemic lupus erythematosus.
@en
Serum soluble markers of immun ...... systemic lupus erythematosus.
@nl
type
label
Serum soluble markers of immun ...... systemic lupus erythematosus.
@en
Serum soluble markers of immun ...... systemic lupus erythematosus.
@nl
prefLabel
Serum soluble markers of immun ...... systemic lupus erythematosus.
@en
Serum soluble markers of immun ...... systemic lupus erythematosus.
@nl
P2093
P2860
P1433
P1476
Serum soluble markers of immun ...... systemic lupus erythematosus.
@en
P2093
E L Nassonov
G Reibnegger
M Y Samsonov
R M Balabanova
V A Nassonova
P2860
P356
10.1177/096120339500400107
P577
1995-02-01T00:00:00Z